ofi Österreichisches forschungsinstitut fÜr chemie … · sensibilisation, endocrine disruptors)...

14
www.ofi.at February 2018 OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE UND TECHNIK TESTING, INSPECTION, CERTIFICATION AND RESEARCH ACTIVITIES

Upload: others

Post on 09-Sep-2019

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

February 2018

OFI – ÖSTERREICHISCHES FORSCHUNGSINSTITUT

FÜR CHEMIE UND TECHNIK

TESTING, INSPECTION, CERTIFICATION

AND RESEARCH ACTIVITIES

Page 2: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

OFI – Who we are and what we do

Found in 1946 as a partner of the Austrian chemical industry

Active in the fields of material technologies and building renovation

104 employees (FTE) and a annual turnover of 14.5 Mio. EUR

Largest private testing, inspection and certification body in Austria with

over 1000 accredited procedures and 550 certificates issued

In addition offering expert opinions, consulting and trainings

Research activities in defined areas make a contribution of 10 % of the

annual turnover

Page 3: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

OFI – Buildings and Renovation

Construction

Engineering

and Renovation

Sports

Technologies

Construction

Products

Construction

Materials

Page 4: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

OFI – Materials Technologies

Packaging and

Food

Piping Technology,

Valves,

Water Treatment

Pharma,

Medical Devices

& Hygiene

Plastic Products,

Coatings

and Bonding

Page 5: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Research Activities

Hygiene

Surfaces - Resistance:

Resistance of materials against disinfecting agents and

disinfection procedures (e.g. Effectivity, Ageing, Residues)

Functional Surfaces:

Developement of antimicrobial surfaces based on chemical and

physical mechanism

Air:

Testing, optimization and development of filters and filter media

for the purpose of reducing biological hazardous substances

(allergens, bacteria, viruses) in interiours.

Page 6: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Research Activities

Medical Devices

Developement of implants and investigation of their

biocompatibility without the use of animal experiments by the

means of in-vitro techniques (Cyto- and genotoxicity, irritation,

sensibilisation, endocrine disruptors)

Biocompatibility concerning inflammatory and allergic reactions

caused by implantates by the means of mass spectrometry (MS)

(Proteomics – Protein analytics)

Development of biocompatible elastic textiles and investigation

of their biocompatibility without the use of animal experiments by

the means of in-vitro techniques (Cyto- and genotoxicity, irritation,

sensibilisation, endocrine disruptors)

Page 7: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Research Activities

www.ofi.at

Quantum (2013) – Development of innovative screening methods

for analysing residues by the means of HPLC/MS

Xeno (2014) – Development of in-vitro methods for the

determination of hormones / endocrine disruptors

Hygo (2015) – Development of innovative hygiene concepts taking

the resistance of materials against disinfection agents and

procedures into consideraton (e.g. Effectivity, Ageing, Residues)

Biorelation (2017) – Development of in-vitro methods for the

investigation on biocompatibility (Cytotoxicity, irritation,

sensibilisation)

Page 8: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Research Activities

www.ofi.at

E.Lyse (2017-2019) and Bikopla (2013-2017): Development of

antimicrobial surfaces based on chemical and physical mechanism

Aeropore (2017-2021): Devolopement and optimization of a test rig

for the investigation of filter modules for the purpose of reducing

biological hazardous substances (allergens, bacteria, viruses) in

interiours

Ortho.flex.c (2016-2019), proTect (2016-2020) and Meditex (2018-

2020): Development of in-vitro and in-chemico methods (animal

experiment free) for the investigation of the biocompatibility of

medical devices

Page 9: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Research Activities

Core topics in the area „food and packaging" are:

Security and quality of food and packagings

Material and product development (Innovative packagings)

Packaging technology and environmental aspects

Page 10: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

CoinSenses:

• Characterisation of plastics concerning recurrent NIAS (Not Intentionally

Added Substances) and the clarification of causes

- Standard plastics are reviewed concerning recurrent NIAS

- Goal is to clarify the origin of the substances

- It there are any odour and/or taste deviations in the organoleptic

tests, the responsible substances are identified

• Part of the project is the identification of influence parameters of the

origin of NIAS

- Sterilisation

- Radiation

- External influences (e.g. light, oxygen)

Research Activities

Page 11: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Development of insulated transport boxes (“Cool Box”):

• Reliable protection of easy perishable food in shipment

• New business opportunities in e-commerce,

delivery by drones and traditional trade

• Framework of the project:

- Stackability of the product

- Usability in a deposit system and in existing washing/drying systems

- Constancy of temperature from 2 °C - 8 °C or 0 °C - 4 °C over 24 h

- Individual identification on outside shall be possible (e.g. EAN code)

- Tamper safety (e.g. by transportation)

- Sustainability of the box

Research Activities

Page 12: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Identification,

optimizing and

development of new

packaging systems

and process concepts

Effects on food waste

at the consumer and

the trade

Holistic assessment

of the ecological and

economical changes

in the life-cycle

Guideline

for packaging

producers, fillers

and trade

Research Activities

Page 13: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

Research Activities

What we are looking for...

Cooperations with universities in the framework of research

projects in particular in the field of biocompatibility, packaging

materials and life-cycle analysis

Specialized chemical analysis, which are not provided by OFI

(e.g molecuar weight distribution)

What we offer...

Cooperations in the field of biocompatibility, packaging materials

ad life-cycle analysis

Support with bringign researchs results to customers and the

market

Testing facilities of OFI can be useful in other research projects

Page 14: OFI ÖSTERREICHISCHES FORSCHUNGSINSTITUT FÜR CHEMIE … · sensibilisation, endocrine disruptors) Biocompatibility concerning inflammatory and allergic reactions caused by implantates

www.ofi.at

CEO

DI Udo PAPPLER

+43 1 798 16 01 - 790

[email protected]

Medical Devices, Hygiene

DI Gabriele Ettenberger

+43 1 798 16 01 - 624

[email protected]

Food and Packaging

DI Dr. Michael Washüttl

+43 1 798 16 01 - 960

[email protected]

www.ofi.at